PRISM BioLab opens a business office in Tokyo

We are pleased to announce the establishment of PRISM BioLab Co., Ltd. Tokyo office. The office was officially opened on September 2, 2024 and will serve as a base for our business and administrative functions, for enhanced communications with our investors and partners, and to enable more effective business decisions.

We sincerely appreciate the continued support and guidance from our investors and business partners and are looking forward to working even more closely through our new Tokyo office.

PRISM BioLab will continue leveraging its proprietary PepMetics® platform technology and working with pharma partners on turning previously “undruggable” into “druggable” targets, with the aim of developing treatments for diseases that currently have no cure.

Come and visit us. The office is located at:
Nihonbashi Life Science Building 3, Room 301, 3-8-3 Nihonbashi-Honcho, Chuo-ku, Tokyo 103-0023, Japan

Dai Takehara
President & CEO
PRISM BioLab Co., Ltd.